|
CDK6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.95919999948602E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.66249999999923E-06 |
| Normal-vs-Stage2 |
5.746400E-02 |
| Normal-vs-Stage3 |
9.82990000000239E-05 |
| Normal-vs-Stage4 |
4.8240000882771E-10 |
| Stage1-vs-Stage2 |
1.838770E-01 |
| Stage1-vs-Stage3 |
8.934400E-01 |
| Stage1-vs-Stage4 |
2.338100E-03 |
| Stage2-vs-Stage3 |
2.352200E-01 |
| Stage2-vs-Stage4 |
2.500600E-03 |
| Stage3-vs-Stage4 |
1.852400E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63099999950234E-07 |
| Normal-vs-AfricanAmerican |
5.385800E-01 |
| Normal-vs-Asian |
1.982930E-04 |
| Caucasian-vs-AfricanAmerican |
1.922220E-01 |
| Caucasian-vs-Asian |
7.547200E-01 |
| AfricanAmerican-vs-Asian |
2.581200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.17940000046823E-07 |
| Normal-vs-Female |
3.80929999999058E-06 |
| Male-vs-Female |
5.172200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.59574999999412E-05 |
| Normal-vs-Age(41-60Yrs) |
1.53099999999906E-06 |
| Normal-vs-Age(61-80Yrs) |
5.648300E-04 |
| Normal-vs-Age(81-100Yrs) |
6.385900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.272400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.021000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.632600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.629400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.058800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.836400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.635400E-01 |
| Classical-VS-Follicular |
1.641750E-02 |
| Classical-VS-Other |
3.916200E-01 |
| Classical-VS-Normal |
1.42370000011383E-07 |
| Tall-VS-Follicular |
1.173630E-01 |
| Tall-VS-Other |
3.679400E-01 |
| Tall-VS-Normal |
6.762600E-03 |
| Follicular-VS-Other |
5.821200E-01 |
| Follicular-VS-Normal |
3.522100E-02 |
| Other-VS-Normal |
8.266600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.56543999999537E-05 |
| Normal-vs-N1 |
6.59583498929806E-13 |
| N0-vs-N1 |
1.7960899999947E-05 |
|
|
